XML 21 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jul. 01, 2018
Jun. 25, 2017
Operating activities    
Net income before attribution to noncontrolling interests $ 30,045 $ 54,881
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision for uncollectible accounts and notes receivable 3,591 (1,091)
Depreciation and amortization 23,270 21,111
Deferred income taxes (2,511) 158
Stock-based compensation expense 4,929 5,571
Loss on refranchising 1,918  
Other 3,032 1,978
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable (148) (355)
Income tax receivable 3,678 (45)
Inventories 3,188 550
Prepaid expenses 1,159 2,966
Other current assets 5,524 (372)
Other assets and liabilities (2,202) (1,559)
Accounts payable 2,511 (3,950)
Income and other taxes payable (1,656) 1,275
Accrued expenses and other current liabilities (2,506) (3,002)
Deferred revenue 379 (253)
Net cash provided by operating activities 74,201 77,863
Investing activities    
Purchases of property and equipment (21,562) (30,457)
Loans issued (1,904) (1,476)
Repayments of loans issued 2,720 2,125
Acquisitions, net of cash acquired   (21)
Proceeds from divestitures of restaurants 3,690  
Other 146 25
Net cash used in investing activities (16,910) (29,804)
Financing activities    
Repayments of term loan (10,000)  
Net proceeds (repayments) of revolving credit facility 119,400 5,156
Cash dividends paid (14,762) (14,703)
Tax payments for equity award issuances (1,353) (2,282)
Proceeds from exercise of stock options 2,179 5,218
Acquisition of Company common stock (148,440) (33,968)
Distributions to noncontrolling interest holders (1,110) (1,389)
Other 231 494
Net cash used in financing activities (53,855) (41,474)
Effect of exchange rate changes on cash and cash equivalents (62) 99
Change in cash and cash equivalents 3,374 6,684
Cash and cash equivalents at beginning of period 22,345 15,563
Cash and cash equivalents at end of period $ 25,719 $ 22,247